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Early childhood developmental disabilities—data still needed
The first 5 years of life form the building blocks 
for lifelong health and wellbeing, as shown by 
epidemiological risk and physiological, psychological, 
and neuroscientific evidence. Advances in research, 
policies, and programmes have resulted in increased 
attention on early childhood development, particularly 
in the Sustainable Development Goal (SDG) era.1 
Although attention on childhood developmental 
disabilities is also increasing, the pace has lagged, partly 
due to data gaps for the prevalence, epidemiology, and 
causes of disabilities in low-income and middle-income 
countries (LMICs).2 Bolajoko Olusanya and colleagues’ 
systematic analysis in The Lancet Global Health for the 
Global Burden of Diseases, Injuries, and Risk Factors 
Study 2016 (GBD 2016) begins to address these gaps by 
estimating the prevalence and years lived with disability 
(YLDs) for six developmental disabilities among children 
younger than 5 years: epilepsy, intellectual disability, 
vision loss, hearing loss, autism spectrum disorder, and 
attention deficit hyperactivity disorder (ADHD).3
GBD 2016 includes data from multiple sources 
(health surveys, systematic reviews, hospital and claims 
databases, case notification systems, and studies of 
specific disabilities, such as epilepsy or autism) and 
uses complex spatiotemporal modelling to produce 
prevalence estimates.3 Although some of these sources 
might include data on children’s medical disabilities, 
neurodevelopmental disabilities such as ADHD do not 
necessarily include medical comorbidities and are often 
undiagnosed before age 5 years. ADHD has traditionally 
been diagnosed during school age when the inattention, 
distractibility, and other behaviours indicative of ADHD 
come into conflict with the demands of primary school.4 
The ADHD diagnosis has been extended to preschool 
children (age 4 years), and screening checklists have been 
validated for use by parents and preschool teachers.5 
Prevalence estimates among young children might 
depend on parents’ ability to recognise symptoms and 
to bring their concerns to the attention of health-care 
providers who must in turn recognise them as symptoms 
of ADHD.4 Children without access to preschool or health-
care services, such as those in rural areas, or with parents 
with limited education and economic means are the least 
likely to be identified; an example of the inverse data law 
whereby those most at risk are least likely to be counted. 
It is therefore not surprising that GBD 2016 reports the 
highest ADHD prevalence in high-income countries 
(HICs; specifically Sweden and Australia), with very low 
prevalence in LMICs.3 Countries with incorrectly reported 
low prevalence of ADHD might not develop policies and 
programmes to diagnose and provide treatment for 
children with ADHD.
Vision and hearing are typically screened by health-
care providers, and vision and hearing loss are the 
most prevalent GBD-reported disabilities.3 Effective 
preventive and treatment interventions have been 
promoted by WHO and governmental and non-
governmental organisations. For example, retinopathy 
of prematurity, a leading cause of childhood blindness, 
is eminently preventable.6 As interventions are scaled 
up and become more broadly available, estimates of 
the burden of vision and hearing loss should include 
not only prevalence, but also the reduction in burden 
associated with the interventions.
Considering the diagnostic controversies associated 
with autism spectrum disorder, it is interesting that 
the condition is included in the GBD 2016 report, while 
the common neuromotor disorder cerebral palsy is 
not fully discussed. The GBD 2016 report incorporates 
cerebral palsy in the prevalence estimates of intellectual 
disabilities. However, 55% of children with cerebral 
palsy do not have intellectual disabilities. Children with 
cerebral palsy and intellectual disabilities have motor 
disabilities and might have an increased risk of medical 
comorbidities, such as epilepsy or autism.7,8 
The prevention and management of disabilities 
depend not only on the prevalence of disabilities, 
but also on the underlying causes and epidemiology. 
Over the past 50 years in HICs, the epidemiology of 
childhood disabilities, and the understanding of the 
causal networks underlying them, have changed. 
Improvements in obstetric and neonatal care have 
reduced brain injuries from birth complications 
and neonatal jaundice (which classically resulted in 
choreoathetoid cerebral palsy). Thus, in HICs, child 
disability, including cerebral palsy, has shifted to include 
more extremely preterm infants (gestational age <26 
weeks).5 In LICs, as child survival improves, half of child 
deaths are in the neonatal period and, as intensive 
newborn care is scaled up and more children survive, 
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multiple causes of brain injury will be more common 
among survivors.
Disability weights underlying the YLDs in the study 
are invariant across geographical locations.3 However, 
children’s development and quality of life are affected 
not only by their disability, but also by family care, home 
resources, and community opportunities.9 Children 
with disabilities in HICs benefit from access to high-
quality health care and educational services, with fewer 
opportunities in LMICs.10 Contextual differences affecting 
children and families are not considered in the YLDs.
In summary, the field of developmental disabilities is 
garnering attention and beginning to make major strides 
in research, interventions, and policies for young children 
with disabilities. The adoption of the UN Convention on 
the Rights of Persons with Disabilities in 2006 provided 
momentum for ensuring that countries have policies 
and programmes to support children with disabilities 
and their families. Although the prevalence estimates 
from GBD 2016 are a first step in recognising the burden 
of developmental disabilities, both improving and 
using the data are crucial next steps. Attention to the 
changing epidemiology of developmental disabilities, 
and to the context provided by countries and families, 
is fundamental to understanding these conditions and 
using evidence  to improve opportunities and quality of 
life for young children with disabilities.
*Maureen M Black, Joy E Lawn
University of Maryland School of Medicine, Baltimore, MD 21201, 
USA (MMB); RTI International, Research Triangle Park, NC, USA 
(MMB); and March Centre, London School of Hygiene and Tropical 
Medicine, London, UK (JEL)  
mblack@som.umaryland.edu
We declare no competing interests.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open 
Access article under the CC BY 4.0 license.
1 Black MM, Walker SP, Fernald LC, et al. Early childhood development 
coming of age: science through the life course. Lancet 2017; 389: 77–90.
2 Maulik PK, Darmstadt GL. Childhood disability in low- and middle-income 
countries: overview of screening, prevention, services, legislation, and 
epidemiology. Pediatrics 2007; 120 (suppl 1): S1–55.
3 Global Research on Developmental Disabilities Collaborators. 
Developmental disabilities among children younger than 5 years in 
195 countries and territories, 1990–2016: a systematic analysis for the 
Global Burden of Disease Study 2016. Lancet Glob Health 2018; published 
online Aug 29. http://dx.doi.org/10.1016/S2214-109X(18)30309-7.
4 Bitta M, Kariuki SM, Abubakar A, Newton CRJC. Burden of 
neurodevelopmental disorders in low and middle-income countries: 
a systematic review and meta-analysis. Wellcome Open Res 2017; 2: 121.
5 Wolraich M, Brown L, Brown RT, et al. ADHD: clinical practice guideline for 
the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity 
disorder in children and adolescents. Pediatrics 2011; 128: 1007–22.
6 Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated 
visual impairment and estimates of retinopathy of prematurity at regional 
and global levels for 2010. Pediatr Res 2013; 74 (suppl 1): 35–49.
7 Reid SM, Meehan EM, Arnup SJ, Reddihough DS. Intellectual disability in 
cerebral palsy: a population-based retrospective study. Dev Med Child Neurol 
2018; 60: 687–94.
8 Burton K, Rogathe J, Whittaker RG, et al. Co-morbidity of epilepsy in 
Tanzanian children: a community-based case-control study. Seizure 2012; 
21: 169–74.
9 Bronfenbrenner U, Morris PA. The bioecological model of human 
development. In: Damon W, Lerner RM, eds. Handbook of child psychology. 
6th edn. New York, NY: John Wiley & Sons, 2006: 793–828.
10 Lawn JE, Blencowe H, Darmstadt GL, Bhutta ZA. Beyond newborn survival: 
the world you are born into determines your risk of disability-free survival. 
Pediatr Res 2013; 74: 1–3.
